# ARYNTA

NDC: 24338-103
Generic name: lisdexamfetamine dimesylate oral
Labeler / Manufacturer: Azurity Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION
Routes: ORAL
Marketing started: 20260320

FDA application: NDA219847

## Active ingredients

- LISDEXAMFETAMINE DIMESYLATE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"24338-103"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=24338-103
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=71cdfc97-96af-4378-a44a-6d5d77e7d6b7